BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30671637)

  • 1. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer.
    Gershman B; Maroni P; Tilburt JC; Volk RJ; Konety B; Bennett CL; Kutikov A; Smaldone MC; Chen V; Kim SP
    World J Urol; 2019 Oct; 37(10):2099-2108. PubMed ID: 30671637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
    J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey.
    Puneet K; Tilburt JC; Volk RJ; Bennett CL; Qureshi Z; Gershman B; Sedlacek HM; Kim SP
    Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13301. PubMed ID: 33112008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.
    Kim SP; Tilburt JC; Shah ND; Yu JB; Konety B; Nguyen PL; Abouassaly R; Williams SB; Gross CP
    Clin Genitourin Cancer; 2019 Jun; 17(3):e472-e481. PubMed ID: 30827923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.
    Bukavina L; Tilburt JC; Konety B; Shah ND; Gross CP; Yu JB; Schumacher F; Kutikov A; Smaldone MC; Kim SP
    Eur Urol Focus; 2020 Mar; 6(2):273-279. PubMed ID: 30219709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared decision making and use of decision AIDS for localized prostate cancer : perceptions from radiation oncologists and urologists.
    Wang EH; Gross CP; Tilburt JC; Yu JB; Nguyen PL; Smaldone MC; Shah ND; Abouassally R; Sun M; Kim SP
    JAMA Intern Med; 2015 May; 175(5):792-9. PubMed ID: 25751604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
    Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
    Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists.
    Kim SP; Meropol NJ; Gross CP; Tilburt JC; Konety B; Yu JB; Abouassaly R; Weight CJ; Williams SB; Shah ND
    Urol Oncol; 2018 Nov; 36(11):501.e15-501.e21. PubMed ID: 30190177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
    Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions.
    Han LC; Delpe S; Shah ND; Ziegenfuss JY; Tilburt JC; Karnes RJ; Nguyen PL; Gross CP; Yu JB; Trinh QD; Sun M; Ranasinghe WK; Kim SP
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):277-83. PubMed ID: 24685153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study.
    Zelic R; Garmo H; Zugna D; Stattin P; Richiardi L; Akre O; Pettersson A
    Eur Urol; 2020 Feb; 77(2):180-188. PubMed ID: 31606332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Decision aids for patients are widely accepted by German urologists : A survey among members of the German Society of Urology (DGU) and the Federation of German Urologists (BDU)].
    Groeben C; Baunacke M; Borkowetz A; Kliesch S; Wülfing C; Ihrig A; Huber J
    Urologe A; 2016 Jun; 55(6):784-91. PubMed ID: 26969330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
    Philippou Y; Raja H; Gnanapragasam VJ
    BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?
    Rubin MA; Bismar TA; Curtis S; Montie JE
    Am J Surg Pathol; 2004 Jul; 28(7):946-52. PubMed ID: 15223967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients.
    Leyh-Bannurah SR; Dell'Oglio P; Tian Z; Schiffmann J; Shariat SF; Suardi N; Francesco M; Alberto B; Heinzer H; Huland H; Graefen M; Budäus L; Karakiewicz PI
    World J Urol; 2017 Feb; 35(2):189-197. PubMed ID: 27289238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models.
    Boehm K; Larcher A; Beyer B; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Heinzer H; Graefen M; Budäus L
    Eur Urol; 2016 Jun; 69(6):1038-43. PubMed ID: 26272236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
    Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
    World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.